TABLE 2

Anthropometric and metabolic data before and after treatment

Control subjectsObese pre-Tx
Obese post-Tx
BPDDietBPDDiet
Body weight (kg)74 ± 8137 ± 25*130 ± 36*104 ± 20117 ± 27
BMI (kg/m2)26.5 ± 1.151.2 ± 8.0*48.2 ± 8.9*39.0 ± 8.343.6 ± 7.1
FFM (kg)52 ± 1075 ± 15*71 ± 21*59 ± 1560 ± 17
FM (kg)22 ± 562 ± 14*59 ± 17*45 ± 1357 ± 14
Waist (cm)76 ± 3143 ± 14*131 ± 25*119 ± 15121 ± 15
WHR0.92 ± 0.060.98 ± 0.070.93 ± 0.10*0.98 ± 0.080.93 ± 0.08
Fasting glucose (mmol/l)5.65 ± 0.565.04 ± 0.774.99 ± 0.915.72 ± 1.096.25 ± 0.73
Plasma leptin (ng/ml)11 ± 346 ± 12*46 ± 7*19 ± 543 ± 10
Fasting insulin (pmol/l)88 ± 11298 ± 140*274 ± 128*84 ± 41305 ± 181
M value (μmol · min−1 · kgffm−1)53 ± 1323 ± 3*28 ± 10*52 ± 1136 ± 20
  • *

    * P < 0.05 or less versus control subjects;

  • P < 0.05 or less for the effect of treatment. Tx, treatment.